Using holograms to evaluate pulmonary vascular anatomy before lung surgery
Preoperative Evaluation of Pulmonary Vascular Anatomy by Augmented Reality (Holograms) in Patients Undergoing Lung Resection
This study is testing if using 3D holograms of lung blood vessels can help doctors plan better surgeries for patients with lung cancer.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 50 (estimated) |
| Ages | 18 Years to 90 Years |
| Sex | All |
| Sponsor | European Institute of Oncology Academic / other |
| Drugs / interventions | chemotherapy |
| Locations | 2 sites (Milan and 1 other locations) |
| Trial ID | NCT04227444 on ClinicalTrials.gov |
What this trial studies
This observational study aims to enhance preoperative evaluations for patients undergoing lung resection for cancer by utilizing augmented reality holograms. Standard preoperative assessments will be conducted, followed by the generation of 3D holographic images from computed tomography scans. These holograms will allow surgeons to visualize and analyze the pulmonary vascular anatomy, including potential anomalies, improving surgical planning and execution. The study will involve collaboration between radiologists and thoracic surgeons to assess the accuracy of these holographic representations.
Who should consider this trial
Good fit: Ideal candidates for this study are adults scheduled for anatomical lung resection due to cancer.
Not a fit: Patients who are younger than 18 years or have contraindications to general anesthesia may not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could lead to safer and more efficient lung surgeries by providing surgeons with better visualization of critical vascular structures.
How similar studies have performed: While augmented reality applications in surgery are emerging, this specific approach using holograms for pulmonary vascular anatomy evaluation is relatively novel.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Planned anatomical resection for lung cancer * Signed and dated informed consent indicating that the patient has been informed of all pertinent aspects of the study. * Willingness and ability to comply with study procedures. Exclusion Criteria: * Age younger than 18 years * Contraindications to general anesthesia * Poor general clinical conditions ( ECOG PS \>=2) * Patients unable to provide informed consent
Where this trial is running
Milan and 1 other locations
- European Institute of Oncology — Milan, Italy (Recruiting)
- European Institue of Oncology — Milan, Italy (Recruiting)
Study contacts
- Study coordinator: Francesco Petrella, MD, PhD
- Email: francesco.petrella@ieo.it
- Phone: 00390294372921
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.